Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity.

× No keyword cloud information.

13 in total

1. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors: Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal: Hum Mol Genet Date: 2010-06-09 Impact factor: 6.150

2. OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE.

Authors: James E Galvin
Journal: Neurodegener Dis Manag Date: 2012-06

3. MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.

Authors: Jaekwang Kim; Hyejin Yoon; Cristina M Ramírez; Sang-Mi Lee; Hyang-Sook Hoe; Carlos Fernández-Hernando; Jungsu Kim
Journal: Exp Neurol Date: 2011-11-18 Impact factor: 5.330

4. Exploring the Effect of Phyllanthus emblica L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer's Disease.

Authors: Md Sahab Uddin; Abdullah Al Mamun; Md Sarwar Hossain; Farjana Akter; Mohammed Ashraful Iqbal; Md Asaduzzaman
Journal: Ann Neurosci Date: 2016-10-04

9. Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Authors: Nicole Gallo-Payet; Marie-Odile Guimond; Lyne Bilodeau; Charlotta Wallinder; Mathias Alterman; Anders Hallberg
Journal: Front Endocrinol (Lausanne) Date: 2011-08-26 Impact factor: 5.555

Review 10. Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?

Authors: David A Loeffler
Journal: J Neuroinflammation Date: 2014-12-05 Impact factor: 8.322

Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity.

1. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

2. OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE.

3. MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.

4. Exploring the Effect of Phyllanthus emblica L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer's Disease.

Review 5. Targeting estrogen receptors for the treatment of Alzheimer's disease.

6. Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease.

7. Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats.

8. Polymorphic structures of Alzheimer's β-amyloid globulomers.

9. Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Review 10. Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?